ATE281163T1 - Synergistiche zusammensetzungen von n- acylhomoserinlaktonen und 4-chinolinonen - Google Patents

Synergistiche zusammensetzungen von n- acylhomoserinlaktonen und 4-chinolinonen

Info

Publication number
ATE281163T1
ATE281163T1 AT02743413T AT02743413T ATE281163T1 AT E281163 T1 ATE281163 T1 AT E281163T1 AT 02743413 T AT02743413 T AT 02743413T AT 02743413 T AT02743413 T AT 02743413T AT E281163 T1 ATE281163 T1 AT E281163T1
Authority
AT
Austria
Prior art keywords
sup
sub
halo
alkyl
group
Prior art date
Application number
AT02743413T
Other languages
English (en)
Inventor
David Pritchard
Original Assignee
Univ Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nottingham filed Critical Univ Nottingham
Application granted granted Critical
Publication of ATE281163T1 publication Critical patent/ATE281163T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02743413T 2001-07-04 2002-07-03 Synergistiche zusammensetzungen von n- acylhomoserinlaktonen und 4-chinolinonen ATE281163T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0116312.0A GB0116312D0 (en) 2001-07-04 2001-07-04 "Compositions containing N-acyl homoserine lactones"
PCT/GB2002/003071 WO2003004017A1 (en) 2001-07-04 2002-07-03 Synergistic compositions of n-acylhomoserine lactones and 4-quinolones

Publications (1)

Publication Number Publication Date
ATE281163T1 true ATE281163T1 (de) 2004-11-15

Family

ID=9917890

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02743413T ATE281163T1 (de) 2001-07-04 2002-07-03 Synergistiche zusammensetzungen von n- acylhomoserinlaktonen und 4-chinolinonen

Country Status (6)

Country Link
US (1) US7371779B2 (de)
EP (1) EP1404315B1 (de)
AT (1) ATE281163T1 (de)
DE (1) DE60201837T2 (de)
GB (1) GB0116312D0 (de)
WO (1) WO2003004017A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1051115C (zh) * 1996-05-22 2000-04-05 天津纺织工学院 调温纤维及其制品
GB0116312D0 (en) 2001-07-04 2001-08-29 Univ Nottingham "Compositions containing N-acyl homoserine lactones"
US7338969B2 (en) 2002-03-08 2008-03-04 Quonova, Llc Modulation of pathogenicity
US7335779B2 (en) 2002-03-08 2008-02-26 Quonova, Llc Modulation of pathogenicity
EP1782826A1 (de) * 2005-11-08 2007-05-09 GBF Gesellschaft für Biotechnologische Forschung mbH PQS, c-di-GMP und deren Konjugate als Ajuvans und deren Verwendung in Pharmazeutische Zusammensetzungen
EP2078713A1 (de) 2007-12-28 2009-07-15 QuoNova GmbH Hemmer der Biofilmbildung grampositiver und gramnegativer Bakterien
EP2448930B1 (de) 2009-07-03 2017-02-15 The National Institute for Biotechnology in the Negev Ltd. N-((S)-2-Oxo-tetrahydro-furan-3-yl)-amid-Derivate als Inhibitoren des bakteriellen Quorum-Sensing zur Behandlung von Pflanzen- oder Tierkrankheiten und zur Verhinderung der Bildung von Biofilmen auf medizinischen Geräten
EP3414229B1 (de) 2016-02-09 2021-06-16 Pharmakea, Inc. Chinolin-lysyl-oxidase-like-2-inhibitoren und verwendungen davon
CN114805049B (zh) * 2022-04-18 2024-08-06 深圳深信生物科技有限公司 一种10-氧代十九烷二酸的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0706393T3 (da) * 1993-07-02 2000-04-03 Univ Nottingham Immun-undertrykkende og antiallergiske forbindelser, f.eks. N-(3-oxohexanoyl)homoserin-lacton
GB0007588D0 (en) 2000-03-30 2000-05-17 Univ Nottingham N-Acyl homoserine lactones
GB0030729D0 (en) * 2000-12-16 2001-01-31 Univ Nottingham Substituted-4-Quinolones
GB0116312D0 (en) 2001-07-04 2001-08-29 Univ Nottingham "Compositions containing N-acyl homoserine lactones"

Also Published As

Publication number Publication date
EP1404315A1 (de) 2004-04-07
DE60201837D1 (de) 2004-12-09
DE60201837T2 (de) 2005-10-27
GB0116312D0 (en) 2001-08-29
US7371779B2 (en) 2008-05-13
US20040198978A1 (en) 2004-10-07
WO2003004017A1 (en) 2003-01-16
EP1404315B1 (de) 2004-11-03

Similar Documents

Publication Publication Date Title
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
ES2185635T3 (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
NO308739B1 (no) Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme
EA199900866A1 (ru) Пиразолопиримидиноны, которые ингибируют циклический гуанозин-3',5'-монофосфат-фосфодиэстеразу типа 5 (cgmp pde5), для лечения сексуального расстройства
EA200400466A1 (ru) Производные пиперазина с антагонистической активностью к рецептору ccr1
ATE235474T1 (de) 4,1-benzoxazepinderivate als squalen-synthetase inhibitoren und ihre verwendung zur behandlung von hypercholesterämie und als fungizide
NZ233015A (en) Acryloyl-substituted pyrrole derivatives (distamycin a analogues) and pharmaceutical compositions
EA200000400A1 (ru) Галогензамещенные тетрациклические производные тетрагидрофурана
BR0307944A (pt) Piranonas úteis como inibidores de atm
ATE281163T1 (de) Synergistiche zusammensetzungen von n- acylhomoserinlaktonen und 4-chinolinonen
NZ513594A (en) Heterocyclic compounds, intermediates thereof and elastase inhibitors
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
YU5199A (sh) Farmaceutski proizvodi za lečenje i sprečavanje bolesti nastalih od oštećenja vaskularnih endotelialnih ćelija
ATE342266T1 (de) 1-methylcarbapenemderivate
WO2002047686A8 (en) Substituted-4-quinolones
KR900003153A (ko) 신규 치환 2-아릴옥시 및 2-아릴티오트리아진 유도체, 그의 제조방법 및 제초제 및 식물 성장 조절제로서 그의 용도
KR890001538A (ko) 동물의 성장촉진제 조성물
DK602383A (da) 1,1-diphenylpropanolderivater
ES2086857T3 (es) Derivados de 3-azabiciclo(3.1.0)hexano-2-ona y composiciones herbicidas que los contienen como ingredientes herbicidamente activos.
GB0114699D0 (en) Organic compounds
DE60111653D1 (de) Aminoflavonverbindungen, zusammensetzungen und ihre verwendung
ATE275542T1 (de) Arthropodische carboxanilide
HRP20090085T3 (en) Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
KR950704243A (ko) 아세트아미드 유도체(acetamide derivative)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties